Image via Wikipedia
VIPs and stars like Federica Panicucci, Ambra Angiolini, Federica Fontana, Justine Mattera, and many others are increasingly choosing to store their umbilical cord stem cells storage banks outside of the country for a possible future autologous (self) use. This has been dubbed as a sort of ‘biological insurance’ on the life of their children, allowed by Italian law only for infants that could help their brothers and sister struck by genetic diseases. These famous moms unknowingly risk spreading a false message, that the storage of umbilical cord stem cells for ‘private use’ is based on definite
THE SWIRL of controversy that greeted President Obama’s executive order lifting the ban on federal funding of stem cell research in March didn’t make a significant return when the final rules were released over the summer. That’s because the National Institutes of Health successfully navigated a minefield of ethical and moral questions. To protect those regulations from politics and changes by another administration, Rep. Diana DeGette (D-Colo.) soon will introduce the Stem Cell Research Enhancement Act of 2009. The legislation would codify Mr. Obama’s executive order permitting federal funding of such research within guidelines established by the NIH and
Image by cap21photo via Flickr
On May 6, France’s Council of State (the highest administrative court and legal advisor to the executive branch) declared that it was against the practice of “renting out one’s uterus” and in favor of the permanent authorization regulations for embryo research and embryonic stem cell research under certain conditions. French Prime Minister Francois Fillon had asked the court for its opinion, in a reexamination of a 2004 bioethics law.
-Considering the interest of the child and the mother carrying the child and basic underlying principles of the present ban, we hereby recommend to not legalize
Image via Wikipedia
Stem cell researchers have a lot of big dreams, and one is to someday regenerate damaged hearts. That is still many years away from becoming a commercial reality, if ever, but a few University of Washington scientists have formed a new company that hopes to make cells that can replace pacemakers, and someday rebuild damaged heart tissue that people are left with after heart attacks.
The company, Bellevue, WA-based Beat BioTherapeutics, is the brainchild of Chuck Murry and Michael Laflamme, a pair of UW stem cell researchers, and UW bioengineering professor Buddy Ratner. It has roots in about
What are mesenchymal stem cells? where are they found in the human body? What are their most promising clinical applications? Gordana Vunjak-Novakovic of Columbia University gives us an answer to these questions and and an outlook on the future of mesenchymal stem cells.